The Multi-Target Drug Design Era is Here, Consider it-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Multi-Target Drug Design Era is Here, Consider it

Published:2012 Issue:1 Volume:1 Page:
ISSN:2169-0138
Container-title:Drug Designing: Open Access
language:
Short-container-title:Drug Design

Author:

Sikazwe Donald

Publisher

OMICS Publishing Group

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual Inhibitors of Brain Carbonic Anhydrases and Monoamine Oxidase-B Efficiently Protect against Amyloid-β-Induced Neuronal Toxicity, Oxidative Stress, and Mitochondrial Dysfunction;Journal of Medicinal Chemistry;2024-03-04

2. Polyfunctional Drugs: Search, Development, Use in Medical Practice, and Environmental Aspects of Preparation and Application (A Review);Russian Journal of General Chemistry;2022-12

3. A photoactivatable chemotherapeutic Ru(II) complex bearing bathocuproine ligand efficiently induces cell death in human malignant melanoma cells through a multi-mechanistic pathway;Chemico-Biological Interactions;2021-10

4. Understanding the Polypharmacological Profiles of Triple Reuptake Inhibitors by Molecular Simulation;ACS Chemical Neuroscience;2021-05-12

5. Drug Re‐positioning Studies for Novel HIV‐1 Inhibitors Using Binary QSAR Models and Multi‐target‐driven In Silico Studies;Molecular Informatics;2020-09-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3